{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:46:04Z","timestamp":1790354764575,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,8,16]],"date-time":"2018-08-16T00:00:00Z","timestamp":1534377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,8,16]],"date-time":"2018-08-16T00:00:00Z","timestamp":1534377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2019,1,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Hepatocellular carcinoma (HCC) is one of the most lethal cancers worldwide. The poor survival may be due to a high proportions of tumor recurrence and metastasis. Kinesin family member C1 (KIFC1) is highly expressed in a variety of neoplasms and is a potential marker for non-small cell lung cancer or ovarian adenocarcinoma metastasis. Nevertheless, the role of KIFC1 in HCC metastasis remains obscure. We investigated this in the present study using HCC cell lines and clinical specimens. Our results indicated that increased levels of KIFC1 were associated with poor prognosis and metastasis in HCC. In addition, KIFC1 induced epithelial-to-mesenchymal transition (EMT) and HCC metastasis both in vitro and in vivo. This tumorigenic effect depended on gankyrin; inhibiting gankyrin activity reversed EMT via activation of protein kinase B (AKT)\/Twist family BHLH transcription factor 1 (AKT\/TWIST1). We also found that KIFC1 was directly regulated by the microRNA miR-532-3p, whose downregulation was associated with metastatic progression in HCC. These results denote that a decrease in miR-532-3p levels results in increased KIFC1 expression in HCC, leading to metastasis via activation of the gankyrin\/AKT\/TWIST1 signaling pathway.<\/jats:p>","DOI":"10.1038\/s41388-018-0440-8","type":"journal-article","created":{"date-parts":[[2018,8,16]],"date-time":"2018-08-16T07:29:37Z","timestamp":1534404577000},"page":"406-420","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["RETRACTED ARTICLE: KIFC1 regulated by miR-532-3p promotes epithelial-to-mesenchymal transition and metastasis of hepatocellular carcinoma via gankyrin\/AKT signaling"],"prefix":"10.1038","volume":"38","author":[{"given":"Jihua","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaliang","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlei","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjian","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruipeng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongsen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangha","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiemin","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changming","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangchao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xirui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanzheng","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifeng","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianzhi","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiewu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,16]]},"reference":[{"key":"440_CR1","first-page":"87","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87\u2013108.","journal-title":"CA Cancer J Clin"},{"key":"440_CR2","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.bpg.2015.09.007","volume":"29","author":"GB Goh","year":"2015","unstructured":"Goh GB, Chang PE, Tan CK. Changing epidemiology of hepatocellular carcinoma in Asia. Best Pract Res Clin Gastroenterol. 2015;29:919\u201328.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"440_CR3","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1053\/j.gastro.2017.02.040","volume":"152","author":"M Serper","year":"2017","unstructured":"Serper M, Taddei TH, Mehta R, D\u2019Addeo K, Dai F, Aytaman A, et al. Association of provider specialty and multi-disciplinary care with hepatocellular carcinoma treatment and mortality. Gastroenterology. 2017;152:1954\u201364.","journal-title":"Gastroenterology"},{"key":"440_CR4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00441-009-0800-3","volume":"337","author":"K Yu","year":"2009","unstructured":"Yu K, Hou L, Zhu JQ, Ying XP, Yang WX. KIFC1 participates in acrosomal biogenesis, with discussion of its importance for the perforatorium in the Chinese mitten crab Eriocheir sinensis. Cell Tissue Res. 2009;337:113\u201323.","journal-title":"Cell Tissue Res"},{"key":"440_CR5","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1091\/mbc.e06-06-0524","volume":"18","author":"S Nath","year":"2007","unstructured":"Nath S, Bananis E, Sarkar S, Stockert RJ, Sperry AO, Murray JW, et al. Kif5B and Kifc1 interact and are required for motility and fission of early endocytic vesicles in mouse liver. Mol Biol Cell. 2007;18:1839\u201349.","journal-title":"Mol Biol Cell"},{"key":"440_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/1757-2215-7-53","volume":"7","author":"S Pawar","year":"2014","unstructured":"Pawar S, Donthamsetty S, Pannu V, Rida P, Ogden A, Bowen N, et al. KIFCI, a novel putative prognostic biomarker for ovarian adenocarcinomas: delineating protein interaction networks and signaling circuitries. J Ovarian Res. 2014;7:53.","journal-title":"J Ovarian Res"},{"key":"440_CR7","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3892\/or.2016.4781","volume":"36","author":"N Oue","year":"2016","unstructured":"Oue N, Mukai S, Imai T, Pham TT, Oshima T, Sentani K, et al. Induction of KIFC1 expression in gastric cancer spheroids. Oncol Rep. 2016;36:349\u201355.","journal-title":"Oncol Rep"},{"key":"440_CR8","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1080\/15384047.2015.1070980","volume":"16","author":"Y Li","year":"2015","unstructured":"Li Y, Lu W, Chen D, Boohaker RJ, Zhai L, Padmalayam I, et al. KIFC1 is a novel potential therapeutic target for breast cancer. Cancer Biol Ther. 2015;16:1316\u201322.","journal-title":"Cancer Biol Ther"},{"key":"440_CR9","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1158\/1078-0432.CCR-08-2124","volume":"15","author":"H Grinberg-Rashi","year":"2009","unstructured":"Grinberg-Rashi H, Ofek E, Perelman M, Skarda J, Yaron P, Hajduch M, et al. The expression of three genes in primary non-small cell lung cancer is associated with metastatic spread to the brain. Clin Cancer Res. 2009;15:1755\u201361.","journal-title":"Clin Cancer Res"},{"key":"440_CR10","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139:871\u201390.","journal-title":"Cell"},{"key":"440_CR11","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.cell.2004.06.006","volume":"117","author":"J Yang","year":"2004","unstructured":"Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell. 2004;117:927\u201339.","journal-title":"Cell"},{"key":"440_CR12","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s12072-015-9634-0","volume":"9","author":"H Zou","year":"2015","unstructured":"Zou H, Feng X, Cao JG. Twist in hepatocellular carcinoma: pathophysiology and therapeutics. Hepatol Int. 2015;9:399\u2013405.","journal-title":"Hepatol Int"},{"key":"440_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/hep.24015","volume":"53","author":"J Fu","year":"2011","unstructured":"Fu J, Chen Y, Cao J, Luo T, Qian YW, Yang W, et al. p28GANK overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3-kinase\/AKT\/hypoxia-inducible factor-1alpha pathways. Hepatology. 2011;53:181\u201392.","journal-title":"Hepatology"},{"key":"440_CR14","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1158\/1078-0432.CCR-16-0851","volume":"23","author":"RM Chang","year":"2017","unstructured":"Chang RM, Xiao S, Lei X, Yang H, Fang F, Yang LY. miRNA-487a promotes proliferation and metastasis in hepatocellular carcinoma. Clin Cancer Res. 2017;23:2593\u2013604.","journal-title":"Clin Cancer Res"},{"key":"440_CR15","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1158\/0008-5472.CAN-16-3236","volume":"77","author":"M Rokavec","year":"2017","unstructured":"Rokavec M, Horst D, Hermeking H. Cellular model of colon cancer progression reveals signatures of mRNAs, miRNA, lncRNAs, and epigenetic modifications associated with metastasis. Cancer Res. 2017;77:1854\u201367.","journal-title":"Cancer Res"},{"key":"440_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.126","volume":"8","author":"J Han","year":"2017","unstructured":"Han J, Xie C, Pei T, Wang J, Lan Y, Huang K, et al. Deregulated AJAP1\/beta-catenin\/ZEB1 signaling promotes hepatocellular carcinoma carcinogenesis and metastasis. Cell Death Dis. 2017;8:e2736.","journal-title":"Cell Death Dis"},{"key":"440_CR17","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.21037\/jtd.2016.10.67","volume":"8","author":"Y Liu","year":"2016","unstructured":"Liu Y, Zhan P, Zhou Z, Xing Z, Zhu S, Ma C, et al. The overexpression of KIFC1 was associated with the proliferation and prognosis of non-small cell lung cancer. J Thorac Dis. 2016;8:2911\u201323.","journal-title":"J Thorac Dis"},{"key":"440_CR18","doi-asserted-by":"publisher","first-page":"48656","DOI":"10.18632\/oncotarget.8799","volume":"7","author":"YX Xiao","year":"2016","unstructured":"Xiao YX, Yang WX. KIFC1: a promising chemotherapy target for cancer treatment? Oncotarget. 2016;7:48656\u201370.","journal-title":"Oncotarget"},{"key":"440_CR19","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1038\/onc.2015.316","volume":"35","author":"J Chen","year":"2016","unstructured":"Chen J, Bai M, Ning C, Xie B, Zhang J, Liao H, et al. Gankyrin facilitates follicle-stimulating hormone-driven ovarian cancer cell proliferation through the PI3K\/AKT\/HIF-1alpha\/cyclin D1 pathway. Oncogene. 2016;35:2506\u201317.","journal-title":"Oncogene"},{"key":"440_CR20","first-page":"1560","volume":"63","author":"MM Riahi","year":"2017","unstructured":"Riahi MM, Sistani NS, Zamani P, Abnous K, Jamialahmadi K. Correlation of gankyrin oncoprotein overexpression with histopathological grade in prostate cancer. Neoplasma. 2017;63:1560\u201375.","journal-title":"Neoplasma"},{"key":"440_CR21","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.prp.2015.09.010","volume":"211","author":"WP Wang","year":"2015","unstructured":"Wang WP, Yan XL, Li WM, Ni YF, Zhao JB, Lu Q, et al. Clinicopathologic features and prognostic implications of gankyrin protein expression in non-small cell lung cancer. Pathol Res Pract. 2015;211:939\u201347.","journal-title":"Pathol Res Pract"},{"key":"440_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0095043","volume":"9","author":"Y Liu","year":"2014","unstructured":"Liu Y, Zhang J, Qian W, Dong Y, Yang Y, Liu Z. et al. Gankyrin is frequently overexpressed in cervical high grade disease and is associated with cervical carcinogenesis and metastasis. PLoS ONE. 2014;9:e95043","journal-title":"PLoS ONE"},{"key":"440_CR23","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/hep.26705","volume":"59","author":"T Zheng","year":"2014","unstructured":"Zheng T, Hong X, Wang J, Pei T, Liang Y, Yin D, et al. Gankyrin promotes tumor growth and metastasis through activation of IL-6\/STAT3 signaling in human cholangiocarcinoma. Hepatology. 2014;59:935\u201346.","journal-title":"Hepatology"},{"key":"440_CR24","doi-asserted-by":"publisher","first-page":"4548","DOI":"10.1158\/0008-5472.CAN-12-4586","volume":"73","author":"Z Bai","year":"2013","unstructured":"Bai Z, Tai Y, Li W, Zhen C, Gu W, Jian Z, et al. Gankyrin activates IL-8 to promote hepatic metastasis of colorectal cancer. Cancer Res. 2013;73:4548\u201358.","journal-title":"Cancer Res"},{"key":"440_CR25","doi-asserted-by":"publisher","first-page":"17206","DOI":"10.18632\/oncotarget.4043","volume":"6","author":"T Pei","year":"2015","unstructured":"Pei T, Li Y, Wang J, Wang H, Liang Y, Shi H, et al. YAP is a critical oncogene in human cholangiocarcinoma. Oncotarget. 2015;6:17206\u201320.","journal-title":"Oncotarget"},{"key":"440_CR26","doi-asserted-by":"publisher","first-page":"5909","DOI":"10.18632\/oncotarget.13947","volume":"8","author":"WP Wang","year":"2017","unstructured":"Wang WP, Sun Y, Lu Q, Zhao JB, Wang XJ, Chen Z, et al. Gankyrin promotes epithelial-mesenchymal transition and metastasis in NSCLC through forming a closed circle with IL-6\/ STAT3 and TGF-beta\/SMAD3 signaling pathway. Oncotarget. 2017;8:5909\u201323.","journal-title":"Oncotarget"},{"key":"440_CR27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ccell.2015.12.005","volume":"29","author":"J Hu","year":"2016","unstructured":"Hu J, Sun T, Wang H, Chen Z, Wang S, Yuan L, et al. MiR-215 is induced post-transcriptionally via HIF-Drosha complex and mediates glioma-initiating cell adaptation to hypoxia by targeting KDM1B. Cancer Cell. 2016;29:49\u201360.","journal-title":"Cancer Cell"},{"key":"440_CR28","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/hep.28445","volume":"63","author":"SL Zhou","year":"2016","unstructured":"Zhou SL, Hu ZQ, Zhou ZJ, Dai Z, Wang Z, Cao Y, et al. miR-28-5p-IL-34-macrophage feedback loop modulates hepatocellular carcinoma metastasis. Hepatology. 2016;63:1560\u201375.","journal-title":"Hepatology"},{"key":"440_CR29","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.cell.2013.12.043","volume":"156","author":"M Mori","year":"2014","unstructured":"Mori M, Triboulet R, Mohseni M, Schlegelmilch K, Shrestha K, Camargo FD, et al. Hippo signaling regulates microprocessor and links cell-density-dependent miRNA biogenesis to cancer. Cell. 2014;156:893\u2013906.","journal-title":"Cell"},{"key":"440_CR30","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1002\/hep.28781","volume":"64","author":"J Wang","year":"2016","unstructured":"Wang J, Xie C, Pan S, Liang Y, Han J, Lan Y, et al. N-myc downstream-regulated gene 2 inhibits human cholangiocarcinoma progression and is regulated by leukemia inhibitory factor\/microRNA-181c negative feedback pathway. Hepatology. 2016;64:1606\u201322.","journal-title":"Hepatology"},{"key":"440_CR31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.7314\/APJCP.2013.14.1.139","volume":"14","author":"BS Zhao","year":"2013","unstructured":"Zhao BS, Liu SG, Wang TY, Ji YH, Qi B, Tao YP, et al. Screening of microRNA in patients with esophageal cancer at same tumor node metastasis stage with different prognoses. Asian Pac J Cancer Prev. 2013;14:139\u201343.","journal-title":"Asian Pac J Cancer Prev"},{"key":"440_CR32","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1097\/SLA.0b013e3182a15bcc","volume":"258","author":"Z Kanaan","year":"2013","unstructured":"Kanaan Z, Roberts H, Eichenberger MR, Billeter A, Ocheretner G, Pan J, et al. A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer. Ann Surg. 2013;258:400\u20138.","journal-title":"Ann Surg"},{"key":"440_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141279","volume":"10","author":"EA Benson","year":"2015","unstructured":"Benson EA, Skaar TC, Liu Y, Nephew KP, Matei D. Carboplatin with decitabine therapy, in recurrent platinum resistant ovarian cancer, alters circulating miRNAs concentrations: a pilot study. PLoS ONE. 2015;10:e0141279.","journal-title":"PLoS ONE"},{"key":"440_CR34","doi-asserted-by":"publisher","first-page":"799","DOI":"10.4149\/neo_2016_518","volume":"63","author":"S Pospisilova","year":"2016","unstructured":"Pospisilova S, Pazourkova E, Horinek A, Brisuda A, Svobodova I, Soukup V, et al. MicroRNAs in urine supernatant as potential non-invasive markers for bladder cancer detection. Neoplasma. 2016;63:799\u2013808.","journal-title":"Neoplasma"},{"key":"440_CR35","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nature10730","volume":"481","author":"CS Ross-Innes","year":"2012","unstructured":"Ross-Innes CS, Stark R, Teschendorff AE, Holmes KA, Ali HR, Dunning MJ, et al. Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature. 2012;481:389\u201393.","journal-title":"Nature"}],"updated-by":[{"DOI":"10.1038\/s41388-025-03527-5","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"record-id":"68264"},{"DOI":"10.1038\/s41388-025-03527-5","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000}}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-018-0440-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-018-0440-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-018-0440-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T16:05:46Z","timestamp":1757088346000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-018-0440-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,16]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,1,17]]}},"alternative-id":["440"],"URL":"https:\/\/doi.org\/10.1038\/s41388-018-0440-8","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,16]]},"assertion":[{"value":"18 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41388-025-03527-5","URL":"https:\/\/doi.org\/10.1038\/s41388-025-03527-5","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}